CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skinner, H. G.
Right arrow Articles by Fuchs, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skinner, H. G.
Right arrow Articles by Fuchs, C. S.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 433-438, May 2003
© 2003 American Association for Cancer Research

Parity, Reproductive Factors, and the Risk of Pancreatic Cancer in Women1

Halcyon G. Skinner2, Dominique S. Michaud, Graham A. Colditz, Edward L. Giovannucci, Meir J. Stampfer, Walter C. Willett and Charles S. Fuchs

Department of Epidemiology [H. G. S., G. A. C., E. L. G., M. J. S., W. C. W.] and Department of Nutrition, Harvard School of Public Health [G. A. C., E. L. G., M. J. S., W. C. W.], Boston, Massachusetts 02115; The Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115 [H. G. S., G. A. C., E. L. G., M. J. S., W. C. W., C. S. F.]; Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115 [C. S. F.]; and Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20892 [D. S. M.]

Incidence rates for pancreatic cancer are consistently lower in women than in men. Previous studies suggest that reproductive factors, particularly parity, may reduce pancreatic cancer risk in women. We examined parity, breast feeding history, age at first birth, menstrual factors, and exogenous hormone use in relation to pancreatic cancer risk in a prospective cohort study of women. Information on parity and other reproductive factors was assessed by questionnaires in 1976 and updated biennially. Multivariate relative risks were adjusted for cigarette smoking, body mass index, diabetes, and height. During 22 years of follow-up (1976–1998), 115,474 women contributed 2.4 million years of person time, and 243 cases of pancreatic cancer were identified. Compared with nulliparous women, the relative risk of pancreatic cancer was 0.86 [95% confidence interval (CI), 0.55–1.36] for women with 1–2 births, 0.75 (95% CI, 0.48–1.17) for 3–4 births, and 0.58 (95% CI, 0.34–0.98) for those with >=5 births after adjusting for other factors. An analysis for linear trend indicates a 10% reduction in risk for each birth (Ptrend = 0.008). Other reproductive factors and exogenous hormone use were not significantly related to pancreatic cancer risk. In this large prospective cohort of women, parity was associated significantly with a reduced risk of pancreatic cancer. Additional studies should examine the physiological or hormonal changes underlying pregnancy or childbirth that may explain this finding.




This article has been cited by other articles:


Home page
GutHome page
J. B Greer and D. C Whitcomb
Role of BRCA1 and BRCA2 mutations in pancreatic cancer
Gut, May 1, 2007; 56(5): 601 - 605.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
U. Nothlings, L. R. Wilkens, S. P. Murphy, J. H. Hankin, B. E. Henderson, and L. N. Kolonel
Vegetable Intake and Pancreatic Cancer Risk: The Multiethnic Cohort Study
Am. J. Epidemiol., January 15, 2007; 165(2): 138 - 147.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. Shen, P. Boffetta, J. H. Olsen, A. Andersen, K. Hemminki, E. Pukkala, E. Tracey, D. H. Brewster, M. L. McBride, V. Pompe-Kirn, et al.
A Pooled Analysis of Second Primary Pancreatic Cancer
Am. J. Epidemiol., March 15, 2006; 163(6): 502 - 511.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. McGrath, D. S. Michaud, and I. De Vivo
Hormonal and Reproductive Factors and the Risk of Bladder Cancer in Women
Am. J. Epidemiol., February 1, 2006; 163(3): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. M. Mondul, C. Rodriguez, E. J. Jacobs, and E. E. Calle
Age at Natural Menopause and Cause-specific Mortality
Am. J. Epidemiol., December 1, 2005; 162(11): 1089 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D. Fesinmeyer, M. A. Austin, C. I. Li, A. J. De Roos, and D. J. Bowen
Differences in Survival by Histologic Type of Pancreatic Cancer
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1766 - 1773.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. J. Duell and E. A. Holly
Reproductive and Menstrual Risk Factors for Pancreatic Cancer: A Population-based Study of San Francisco Bay Area Women
Am. J. Epidemiol., April 15, 2005; 161(8): 741 - 747.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Helle, V. Lummaa, and J. Jokela
Accelerated immunosenescence in preindustrial twin mothers
PNAS, August 17, 2004; 101(33): 12391 - 12396.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.